Explainer: Covid-19 treatment options in the GCC
Gulf Business|January 2021
Pharma firm Gilead Sciences is in the process of receiving authorisations for its drug remdesivir across all the Gulf states
Ayman Elsayes

With your drug remdesivir receiving FDA approval for Covid-19 treatment, what is the process for getting approval for its usage in the GCC?

The US Food and Drug Administration approval for remdesivir was granted on October 22, 2020. In the GCC, we initiated discussions with national regulatory authorities in May 2020 to identify the most appropriate regulatory pathways for the registration of remdesivir. The current authorisations are at the federal level in each of the GCC countries, with approval already received in the UAE and emergency use authorisation in place in other GCC countries including Saudi Arabia, where the process for a full marketing authorisation approval by the Saudi Food and Drug Authority is in its final step.

While Covid-19 vaccines are receiving heightened attention, are there also several treatment options undergoing trials worldwide?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM GULF BUSINESSView All

Green lights

It hasn’t even been a full year that Stellantis, one of the world’s biggest auto companies, has been in existence. Still, its wheels are spinning furiously. Here’s what it has in store for the region

6 mins read
Gulf Business
December 2021

Purpose through corporate responsibility

Every organisation must deeply reflect about whether they are leaving behind a legacy or a liability, says Abdulaziz AlSowailim, EY MENA chairman and CEO

5 mins read
Gulf Business
December 2021

Analysing the layers of a coconut

When we have a sense of clarity as to our purpose in life, then we institute the correct practices and habits around us, and set realistic and achievable results

3 mins read
Gulf Business
December 2021

DUNES TO DOMINION

FOR A COUNTRY RICH IN TRADITION AND DRIVEN BY AMBITION, THE UAE’S JOURNEY DURING THE PAST 50 YEARS HAS BEEN UNPRECEDENTED. WHAT’S IN STORE FOR THE NEXT 50?

9 mins read
Gulf Business
December 2021

Building strong

International investors are boosting Dubai’s residential property market, which has rebounded strongly from the Covid crisis, writes Aarti Nagraj

3 mins read
Gulf Business
December 2021

CHASING THE AMERCIAN DREAM

FOR SHAI ZAMANIAN, THE US IS A LAND OF LIMITLESS POSSIBILITIES, AN AVENUE HE AIMS TO OPEN FOR FAMILIES WORLDWIDE VIA IMMIGRATION. HERE’S HOW HE IS BRINGING HIS GOAL TO FRUITION

6 mins read
Gulf Business
December 2021

OBITUARY: JOCELYN HENDERSON (1921-2021)

THE GRANDE DAME OF ABU DHABI – THE WIFE OF A FORMER DIPLOMAT – PASSED AWAY IN THE UAE CAPITAL AGED 100

3 mins read
Gulf Business
December 2021

THE DIGITAL DISRUPTORS

IN THE COMING YEARS, THE GCC IS EXPECTED TO PLAY A SIGNIFICANT ROLE IN SECTORS SUCH AS HEALTHCARE, MANUFACTURING, EDUCATION AND RETAIL, WHICH WILL HELP BOOST THE GROWTH OF ITS NON-OIL ECONOMY

7 mins read
Gulf Business
December 2021

Signed, sealed, delivered

Nicolas Baretzki, CEO of Montblanc, partnered with one of the world’s most recognisable luxury brands, Ferrari, earlier this year. Here’s where the partnership, and the German company as well, is headed next

6 mins read
Gulf Business
December 2021

UP, UP AND AWAY

AS THE FIRST IN-PERSON AIRSHOW TO TAKE PLACE SINCE THE OUTBREAK OF THE PANDEMIC, THE EVENT SAW SEVERAL DEALS ANNOUNCED

4 mins read
Gulf Business
December 2021
RELATED STORIES

The Next Abortion Battle

If the Supreme Court reverses Roe v. Wade, the fight will shift to access to the abortion pill

5 mins read
Bloomberg Businessweek
May 09, 2022

THE ABORTION PILL'S EXILE IN OBSCURITY

Twenty-one years after its approval by the FDA, mifepristone could—but probably won’t— revolutionize a post-Roe world

10+ mins read
Bloomberg Businessweek
February 21 - 28, 2022 (Double Issue)

Covid's Unseen Victims

Extra duties and depleted ranks have pharmacy workers buckling under the pressure

6 mins read
Bloomberg Businessweek
January 31, 2022

Label Lingo

"An expert translates the jargon on your furry friend's food packaging so you know just which bag to put in your cart."

2 mins read
Taste of Home
February - March 2022

Covid Pills Face a Truth Problem

Merck’s new medicine is set to enter a landscape where misinformation is widespread

6 mins read
Bloomberg Businessweek
December 13, 2021

The Future of...Fixing Pharmaceuticals

Eric Edwards is cofounder and chief executive officer of Phlow, a public benefit pharmaceutical corporation. He previously co-founded pharmaceutical company Kaléo, where, among other roles, he was responsible for overall scientific strategy and pharmaceutical development programs. Following an unprecedented year for the pharmaceutical industry, including leaps in vaccine technology and supply chain shortages, Inc. asked Edwards to share his vision for the future of pharmaceuticals.

1 min read
Inc.
Winter 2021/2022

Ready Aim Omicron!

Drugmakers always knew variants would arise. The latest will test their preparedness

5 mins read
Bloomberg Businessweek
December 06, 2021

Prescription for 2022 - These Health Care Stocks Should Thrive

Pharmaceutical and health sciences firms are riding powerful demographic trends amid a golden age of innovation.

7 mins read
Kiplinger's Personal Finance
January 2022

Playing Catchup on COVID

Scientists are testing new antiviral drugs, but they won’t be ready in time for the current wave of cases

6 mins read
Newsweek
October 08, 2021

Finally, a Drug for Alzheimer's?

After scores of failed drugs, the FDA is set to rule on a controversial candidate

7 mins read
Bloomberg Businessweek
May 17, 2021